Authors:
LLOYD GK
MENZAGHI F
BONTEMPI B
SUTO C
SIEGEL R
AKONG M
STAUDERMAN K
VELICELEBI G
JOHNSON E
HARPOLD MM
RAO TS
SACAAN AI
CHAVEZNORIEGA LE
WASHBURN MS
VERNIER JM
COSFORD NDP
MCDONALD LA
Citation: Gk. Lloyd et al., THE POTENTIAL OF SUBTYPE-SELECTIVE NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR AGONISTS AS THERAPEUTIC AGENTS, Life sciences, 62(17-18), 1998, pp. 1601-1606
Authors:
STAUDERMAN KA
MAHAFFY LS
AKONG M
VELICELEBI G
CHAVEZNORIEGA LE
CRONA JH
JOHNSON EC
ELLIOTT KJ
GILLESPIE A
REID RT
ADAMS P
HARPOLD MM
COREYNAEVE J
Citation: Ka. Stauderman et al., CHARACTERIZATION OF HUMAN RECOMBINANT NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR SUBUNIT COMBINATIONS ALPHA-2-BETA-4, ALPHA-3-BETA-4 AND ALPHA-4-BETA-4 STABLY EXPRESSED IN HEK293 CELLS, The Journal of pharmacology and experimental therapeutics, 284(2), 1998, pp. 777-789
Authors:
DAGGETT LP
SACAAN AI
AKONG M
RAO SP
HESS SD
LIAW C
URRUTIA A
JACHEC C
ELLIS SB
DREESSEN J
KNOPFEL T
LANDWEHRMEYER GB
TESTA CM
YOUNG AB
VARNEY M
JOHNSON EC
VELICELEBI G
Citation: Lp. Daggett et al., MOLECULAR AND FUNCTIONAL-CHARACTERIZATION OF RECOMBINANT HUMAN METABOTROPIC GLUTAMATE-RECEPTOR SUBTYPE-5, Neuropharmacology, 34(8), 1995, pp. 871-886